{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:55:47Z","timestamp":1776578147111,"version":"3.51.2"},"reference-count":55,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2,19]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Radiation exposure is a possible predisposing factor for monoclonal gammopathy of undetermined significance (MGUS), but the association has been uncertain. We investigated the relationship between radiation exposure and MGUS prevalence by using data from the M-protein screening for Nagasaki atomic bomb survivors between 1988 and 2004. Radiation exposure was assessed by exposure distance from the hypocenter and exposure radiation dose. We computed prevalence ratios (PRs) and the 95% confidence intervals (CIs) adjusting for exposure age and sex. A total of 1082 cases of MGUS were identified from 52\u2009525 participants. MGUS prevalence was significantly higher in people exposed at distance within 1.5 km than beyond 3.0 km (PR, 1.4; 95% CI, 1.1-1.9) among those exposed at age 20 years or younger, but it was not found among those exposed at age 20 years or older. MGUS prevalence was also significantly higher in people exposed to more than 0.1 Gy than those exposed to less than 0.01 Gy (PR, 1.7; 95% CI, 1.0-2.8) among those exposed at age 20 years or younger. Thus, people exposed at younger age exhibited a significantly high risk of MGUS when exposed to a high radiation dose. There was no clear association between radiation exposure and the malignant progression of MGUS. Further detailed analysis is needed.<\/jats:p>","DOI":"10.1182\/blood-2008-05-159665","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T01:06:55Z","timestamp":1223687215000},"page":"1639-1650","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":39,"title":["Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors"],"prefix":"10.1182","volume":"113","author":[{"given":"Masako","family":"Iwanaga","sequence":"first","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masuko","family":"Tagawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nagasaki Atomic Bomb Casualty Council Health Management Center, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Tsukasaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nagasaki Atomic Bomb Casualty Council Health Management Center, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Yokota","sequence":"additional","affiliation":[{"name":"Biostatistics Section, Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabro","family":"Momita","sequence":"additional","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimeru","family":"Kamihira","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Tomonaga","sequence":"additional","affiliation":[{"name":"Department of Hematology and Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111722184931400_B1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance: natural history in 241 cases.","volume":"64","author":"Kyle","year":"1978","journal-title":"Am J Med"},{"key":"2019111722184931400_B2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis of monoclonal gammopathy of undetermined significance.","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"2019111722184931400_B3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0025-6196(11)61086-0","article-title":"Monoclonal gammopathy of undetermined significance: genetic vs environmental etiologies.","volume":"82","author":"Munshi","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"2019111722184931400_B4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"key":"2019111722184931400_B5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature.","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"key":"2019111722184931400_B6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2307\/3579020","article-title":"Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries.","volume":"142","author":"Cardis","year":"1995","journal-title":"Radiat Res"},{"key":"2019111722184931400_B7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1047-2797(99)00036-8","article-title":"A case control study of multiple myeloma at four nuclear facilities.","volume":"10","author":"Wing","year":"2000","journal-title":"Ann Epidemiol"},{"key":"2019111722184931400_B8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/oem.60.3.165","article-title":"Follow up of mortality and incidence of cancer 1952-98 in men from the UK who participated in the UK's atmospheric nuclear weapon tests and experimental programmes.","volume":"60","author":"Muirhead","year":"2003","journal-title":"Occup Environ Med"},{"key":"2019111722184931400_B9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/bmj.300.6733.1161","article-title":"Follow up of New Zealand participants in British atmospheric nuclear weapons tests in the Pacific.","volume":"300","author":"Pearce","year":"1990","journal-title":"BMJ"},{"key":"2019111722184931400_B10","first-page":"323","article-title":"Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950\u201376: relationship to radiation dose absorbed by marrow.","volume":"69","author":"Ichimaru","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"2019111722184931400_B11","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2307\/3578893","article-title":"Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.","volume":"137","author":"Preston","year":"1994","journal-title":"Radiat Res"},{"key":"2019111722184931400_B12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-8652(199607)52:3<217::AID-AJH15>3.0.CO;2-C","article-title":"Risk of monoclonal gammopathy of undetermined significance: a case-referent study.","volume":"52","author":"Pasqualetti","year":"1996","journal-title":"Am J Hematol"},{"key":"2019111722184931400_B13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2141.2003.04287.x","article-title":"Monoclonal gammopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma.","volume":"121","author":"Neriishi","year":"2003","journal-title":"Brit J Haematol"},{"key":"2019111722184931400_B14","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","article-title":"Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.","volume":"82","author":"Iwanaga","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"2019111722184931400_B15","first-page":"67","article-title":"Late hematological effects in the atomic bomb survivors.","volume-title":"Radiation Risk Perspectives","author":"Tsukasaki","year":"2007"},{"key":"2019111722184931400_B16","first-page":"52","article-title":"Medical database for the atomic bomb survivors at Nagasaki University.","volume":"37","author":"Mori","year":"1992","journal-title":"Acta Med Nagasaki"},{"key":"2019111722184931400_B17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00004032-199605000-00017","article-title":"Estimation of radiation dose for atomic-bomb survivors in the Hiroshima University Registry.","volume":"70","author":"Hoshi","year":"1996","journal-title":"Health Phys"},{"key":"2019111722184931400_B18","article-title":"US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki, Final Report.","author":"Roesch","year":"1987"},{"key":"2019111722184931400_B19","first-page":"119","article-title":"Comparison between DS86 and ABS93D. Studies on radiation effects for atomic bomb survivors.","author":"Hayakawa","year":"1994"},{"key":"2019111722184931400_B20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jnci\/djn045","article-title":"Solid cancer incidence in atomic bomb survivors exposed in utero or as young children.","volume":"100","author":"Preston","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2019111722184931400_B21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1667\/RR3049","article-title":"Studies of mortality of atomic bomb survivors, report 13: solid cancer and noncancer disease mortality: 1950-1997.","volume":"160","author":"Preston","year":"2003","journal-title":"Radiat Res"},{"key":"2019111722184931400_B22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","article-title":"Easy SAS calculations for risk or prevalence ratios and differences.","volume":"162","author":"Spiegelman","year":"2005","journal-title":"Am J Epidemiol"},{"key":"2019111722184931400_B23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-8-9","article-title":"A comparison of two methods for estimating prevalence ratios.","volume":"8","author":"Petersen","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"2019111722184931400_B24","first-page":"716","article-title":"A new look at the statistical model identification.","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trend"},{"key":"2019111722184931400_B25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2307\/3577733","article-title":"Allowing for random errors in radiation dose estimates for the atomic bomb survivor data.","volume":"123","author":"Pierce","year":"1990","journal-title":"Radiat Res"},{"key":"2019111722184931400_B26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.leukres.2008.02.026","article-title":"Waldenstr\u00f6m's macroglobulinemia in a 10-year stable IgG monoclonal gammopathy of undetermined significance.","volume":"33","author":"Iwanaga","year":"2009","journal-title":"Leuk Res"},{"key":"2019111722184931400_B27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1349-7006.2007.00657.x","article-title":"Incidence of multiple primary cancers in Nagasaki atomic bomb survivors: association with radiation exposure.","volume":"99","author":"Nakashima","year":"2008","journal-title":"Cancer Sci"},{"key":"2019111722184931400_B28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0301-472X(02)00802-0","article-title":"Hematologic consequences of exposure to ionizing radiation.","volume":"30","author":"Dainiak","year":"2002","journal-title":"Exp Hematol"},{"key":"2019111722184931400_B29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0753-3322(02)00194-4","article-title":"Myeloma aetiology and epidemiology.","volume":"56","author":"Morgan","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"2019111722184931400_B30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2307\/3576087","article-title":"A further update of the analysis of mortality of workers in a nuclear facility.","volume":"95","author":"Tolley","year":"1983","journal-title":"Radiat Res"},{"key":"2019111722184931400_B31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004032-198901000-00001","article-title":"Mortality of workers at the Hanford site: 1945-1981.","volume":"56","author":"Gilbert","year":"1989","journal-title":"Health Phys"},{"key":"2019111722184931400_B32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00004032-199306000-00001","article-title":"Mortality of workers at the Hanford site: 1945-1986.","volume":"64","author":"Gilbert","year":"1993","journal-title":"Health Phys"},{"key":"2019111722184931400_B33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/bmj.293.6551.845","article-title":"Mortality of workers at the Sellafield plant of British Nuclear Fuels.","volume":"293","author":"Smith","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2019111722184931400_B34","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/bjc.1994.479","article-title":"Cancer mortality and morbidity among workers at the Sellafield plant of British Nuclear Fuels.","volume":"70","author":"Douglas","year":"1994","journal-title":"Br J Cancer"},{"key":"2019111722184931400_B35","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.bjc.6690207","article-title":"Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels.","volume":"79","author":"Omar","year":"1999","journal-title":"Br J Cancer"},{"key":"2019111722184931400_B36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1667\/RR0553.1","article-title":"The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks.","volume":"167","author":"Cardis","year":"2007","journal-title":"Radiat Res"},{"key":"2019111722184931400_B37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bmj.296.6618.332","article-title":"A summary of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes.","volume":"296","author":"Darby","year":"1988","journal-title":"BMJ"},{"key":"2019111722184931400_B38","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/bmj.307.6918.1530","article-title":"Further follow-up of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes.","volume":"307","author":"Darby","year":"1993","journal-title":"BMJ"},{"key":"2019111722184931400_B39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1018407927076","article-title":"Further follow-up of New Zealand participants in United Kingdom atmospheric nuclear weapons tests in the Pacific.","volume":"8","author":"Pearce","year":"1997","journal-title":"Cancer Causes Control"},{"key":"2019111722184931400_B40","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2105\/AJPH.85.4.523","article-title":"Cancer mortality risk among military participants of a 1958 atmospheric nuclear weapons test.","volume":"85","author":"Watanabe","year":"1995","journal-title":"Am J Public Health"},{"key":"2019111722184931400_B41","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jama.1991.03460100092031","article-title":"Diagnostic X-ray procedures and risk of leukemia, lymphoma, and multiple myeloma.","volume":"265","author":"Boice","year":"1991","journal-title":"JAMA"},{"key":"2019111722184931400_B42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ijc.2910590307","article-title":"Cancer mortality following X-ray treatment for ankylosing spondylitis.","volume":"59","author":"Weiss","year":"1994","journal-title":"Int J Cancer"},{"key":"2019111722184931400_B43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ijc.2910560606","article-title":"Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica.","volume":"56","author":"Darby","year":"1994","journal-title":"Int J Cancer"},{"key":"2019111722184931400_B44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2307\/3577477","article-title":"Radiation dose and second cancer risk in patients treated for cancer of the cervix.","volume":"116","author":"Boice","year":"1988","journal-title":"Radiat Res"},{"key":"2019111722184931400_B45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jama.1990.03450050059028","article-title":"Cancer risk among atomic bomb survivors: The RERF Life Span Study: Radiation Effects Research Foundation.","volume":"264","author":"Shimizu","year":"1990","journal-title":"JAMA"},{"key":"2019111722184931400_B46","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.2002.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"key":"2019111722184931400_B47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"2019111722184931400_B48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4065\/82.4.428","article-title":"Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size.","volume":"82","author":"Rosi\u00f1ol","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"2019111722184931400_B49","first-page":"319","article-title":"Healthy screenee bias in epidemiologic studies of cancer incidence.","volume":"7","author":"Weiss","year":"1996","journal-title":"Epidemiology"},{"key":"2019111722184931400_B50","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1038\/sj.onc.1207044","article-title":"Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation.","volume":"22","author":"Lorimore","year":"2003","journal-title":"Oncogene"},{"key":"2019111722184931400_B51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions.","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2019111722184931400_B52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1470-2045(03)01195-1","article-title":"New insights into the pathophysiology of multiple myeloma.","volume":"4","author":"Seidl","year":"2003","journal-title":"Lancet Oncol"},{"key":"2019111722184931400_B53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa0708704","article-title":"Familial myeloma.","volume":"359","author":"Lynch","year":"2008","journal-title":"N Engl J Med"},{"key":"2019111722184931400_B54","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"key":"2019111722184931400_B55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mrfmmm.2005.03.035","article-title":"Untargeted effects of ionizing radiation: implications for radiation pathology.","volume":"597","author":"Wright","year":"2006","journal-title":"Mutat Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/8\/1639\/1488724\/zh800809001639.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/8\/1639\/1488724\/zh800809001639.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T14:54:38Z","timestamp":1709304878000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/8\/1639\/26022\/Relationship-between-monoclonal-gammopathy-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,2,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-05-159665","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,19]]}}}